Controlled Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Add like
Add dislike
Add to saved papers

Tibial and gastrocnemian vein response to LBNP after a 60 day bedrest with and without counter-measures (WISE study).

UNLABELLED: The objective was to quantify calf vein cross section area (CSA) maximal enlargement and the percent change in response to LBNP (lower body negative pressure) after a 60 day bedrest.

METHOD: The 24 healthy volunteers (25-40 y) of the WISE 60 day HDT(-6 degree) bedrest, were divided into 3 groups: Control (Co), Exercise countermeasure (Ex: treadmill under LBNP and flywheel), Nutrition (Nut: daily protein supplement). All were studied at -45mmHg LBNP pre and at HDT day 55. Posterior Tibial (Tib), and Gastrocnemian (Gast) vein were investigated by echography using an echographic probe fixed at the upper and posterior part of the calf. From the post HDT CSE test the subjects were identified as finisher or non finisher to the 10-min tilt tolerance test.

RESULTS: At LBNP-45mmHg, the maximal enlargement of the Tib and Gast veins remained constant pre, and at HDT day 55 in all group (Co, Ex, Nut, finisher, non finisher). For both veins there was a higher vein distension (percent change from supine rest to -45mmHg) in Co and Nut group compared to Ex group despite the maximal distension was similar in all groups. Also the vein distension was higher in non finisher than in finisher.

CONCLUSION: The maximal distension of the vein were not affected nor by HDT nor by CM. The Ex counter-measure minimized the bed rest effect on leg vein distensibility (percent CSA change) while the Nut countermeasure had no effect. Higher leg vein distensibility was associated with reduced orthostatic tolerance.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app